Literature DB >> 8881954

The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.

E Rogers1, T Gürpinar, O Dillioglugil, M W Kattan, J R Goad, P T Scardino, D P Griffith.   

Abstract

OBJECTIVE: To examine the usefulness of clinical stage, tumour differentiation and prostate-specific antigen (PSA) level, alone and in combination, to predict regional nodal metastases in individual patients with localized prostate cancer. PATIENTS AND METHODS: The usefulness of digital rectal examination (DRE), biopsy Gleason sum and PSA, alone and in combination, to predict nodal metastases in an individual patient was examined. The study included 689 patients who had laparoscopic or open pelvic lymph node dissection for clinical stage T1-3 prostate cancer. The Kruskal-Wallis test, Mantel-Haenszel test, chi-squared test and logistic regression were used for continuous, ordinal, categorical, and multivariate analysis, respectively.
RESULTS: Of the 689 patients who underwent radical prostatectomy, 52 (8%) had nodal metastases. Although clinical stage, DRE, pre-operative PSA level and biopsy Gleason sum were significantly related in the univariate analysis, only pre-operative PSA level and biopsy Gleason sum were significant predictors of lymph node status in a multivariate analysis. However, based on a receiver operating characteristic curve, a model with satisfactory sensitivity and specificity could not be obtained.
CONCLUSION: Current estimations of primary prostate cancer biology using pre-operative PSA level, clinical stage and biopsy Gleason sum are not sufficiently sensitive to predict nodal metastases, and pelvic lymphadenectomy remains the definitive method of detection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881954     DOI: 10.1046/j.1464-410x.1996.00117.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.

Authors:  Joseph L Chin; John Srigley; Linda A Mayhew; R Bryan Rumble; Claire Crossley; Amber Hunter; Neil Fleshner; Bish Bora; Robin McLeod; Sheila McNair; Bernard Langer; Andrew Evans
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

2.  Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men.

Authors:  Cheryn Song; Taejin Kang; Jae Y Ro; Moo-Song Lee; Choung-Soo Kim; Hanjong Ahn
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 3.  Should laparoscopy be the standard approach used for pelvic lymph node dissection?

Authors:  J C Kim; G S Gerber
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.